CRUK Formulation Unit for the pharmaceutical and biopharmaceutical evaluation of newanti-cancer drugs

Halbert, Gavin (Principal Investigator)

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Project: Research

Status	Finished
Effective start/end date	1/04/10 → 30/09/15

Funding

Cancer Research UK CRUK: £1,206,468.00
Cancer Research UK CRUK: £1,454,634.00
Cancer Research UK CRUK: £1,083,964.00
Cancer Research UK CRUK: £1,324,993.00
Cancer Research UK CRUK: £555,992.80
Cancer Research UK CRUK: £1,072,180.00